Insulin Delivery Devices Market by Product Type, by End User and by Region- Global Opportunities & Forecast, 2022-2029
Insulin Delivery Devices Market by Product Type (Insulin Pens, Insulin Pumps, Pen Needles, Insulin Syringes and Others), by End User (Patients/Homecare and Hospitals & Clinics) and by Region
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Insulin Delivery Devices Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Insulin Delivery Devices Market Revenue Forecast till 2029
5. Global Insulin Delivery Devices Market by Product Type Revenue Forecast till 2029
5.1. Insulin Pens
5.1.1. Reusable Insulin Pens
5.1.2. Disposable Insulin Pens
5.2. Insulin Pumps
5.2.1. External/Tethered Pumps
5.2.2. Patch Pumps
5.3. Pen Needles
5.3.1. Standard Pen Needles
5.3.2. Safety Pen Needles
5.4. Insulin Syringes
5.5. Others
6. Global Insulin Delivery Devices Market by End User Revenue Forecast till 2029
6.1. Patients/Homecare
6.2. Hospitals & Clinics
7. Global Insulin Delivery Devices Market by Region Forecast till 2029
7.1. North America Insulin Delivery Devices Market Revenue Forecast till 2029
(Option 1: As a part of the free 25% customization)
7.1.1. North America Insulin Delivery Devices Market by Product Type
7.1.1.1. Insulin Pens
7.1.1.1.1. Reusable Insulin Pens
7.1.1.1.2. Disposable Insulin Pens
7.1.1.2. Insulin Pumps
7.1.1.2.1. External/Tethered Pumps
7.1.1.2.2. Patch Pumps
7.1.1.3. Pen Needles
7.1.1.3.1. Standard Pen Needles
7.1.1.3.2. Safety Pen Needles
7.1.1.4. Insulin Syringes
7.1.1.5. Others
7.1.2. North America Insulin Delivery Devices Market by End User
7.1.2.1. Patients/Homecare
7.1.2.2. Hospitals & Clinics
7.1.3. United States of America (US) Insulin Delivery Devices Market All-Up
7.1.4. Canada Insulin Delivery Devices Market All-Up
7.2. Europe Insulin Delivery Devices Market Revenue Forecast till 2029
(Option 2: As a part of the free 25% customization)
7.2.1. Europe Insulin Delivery Devices Market by Product Type
7.2.1.1. Insulin Pens
7.2.1.1.1. Reusable Insulin Pens
7.2.1.1.2. Disposable Insulin Pens
7.2.1.2. Insulin Pumps
7.2.1.2.1. External/Tethered Pumps
7.2.1.2.2. Patch Pumps
7.2.1.3. Pen Needles
7.2.1.3.1. Standard Pen Needles
7.2.1.3.2. Safety Pen Needles
7.2.1.4. Insulin Syringes
7.2.1.5. Others
7.2.2. Europe Insulin Delivery Devices Market by End User
7.2.2.1. Patients/Homecare
7.2.2.2. Hospitals & Clinics
7.2.3. United Kingdom (UK) Insulin Delivery Devices Market All-Up
7.2.4. Germany Insulin Delivery Devices Market All-Up
7.2.5. France Insulin Delivery Devices Market All-Up
7.2.6. Spain Insulin Delivery Devices Market All-Up
7.2.7. Rest of Europe Insulin Delivery Devices Market All-Up
7.3. Asia-Pacific Insulin Delivery Devices Market Revenue Forecast till 2029
(Option 3: As a part of the free 25% customization)
7.3.1. Asia-Pacific Insulin Delivery Devices Market by Product Type
7.3.1.1. Insulin Pens
7.3.1.1.1. Reusable Insulin Pens
7.3.1.1.2. Disposable Insulin Pens
7.3.1.2. Insulin Pumps
7.3.1.2.1. External/Tethered Pumps
7.3.1.2.2. Patch Pumps
7.3.1.3. Pen Needles
7.3.1.3.1. Standard Pen Needles
7.3.1.3.2. Safety Pen Needles
7.3.1.4. Insulin Syringes
7.3.1.5. Others
7.3.2. Asia-Pacific Insulin Delivery Devices Market by End User
7.3.2.1. Patients/Homecare
7.3.2.2. Hospitals & Clinics
7.3.3. China Insulin Delivery Devices Market All-Up
7.3.4. India Insulin Delivery Devices Market All-Up
7.3.5. Japan Insulin Delivery Devices Market All-Up
7.3.6. Rest of APAC Insulin Delivery Devices Market All-Up
7.4. RoW Insulin Delivery Devices Market Revenue Forecast till 2029
(Option 4: As a part of the free 25% customization)
7.4.1. RoW Insulin Delivery Devices Market by Product Type
7.4.1.1. Insulin Pens
7.4.1.1.1. Reusable Insulin Pens
7.4.1.1.2. Disposable Insulin Pens
7.4.1.2. Insulin Pumps
7.4.1.2.1. External/Tethered Pumps
7.4.1.2.2. Patch Pumps
7.4.1.3. Pen Needles
7.4.1.3.1. Standard Pen Needles
7.4.1.3.2. Safety Pen Needles
7.4.1.4. Insulin Syringes
7.4.1.5. Others
7.4.2. RoW Insulin Delivery Devices Market by End User
7.4.2.1. Patients/Homecare
7.4.2.2. Hospitals & Clinics
7.4.3. Brazil Insulin Delivery Devices Market All-Up
7.4.4. South Africa Insulin Delivery Devices Market All-Up
7.4.5. Saudi Arabia Insulin Delivery Devices Market All-Up
7.4.6. UAE Insulin Delivery Devices Market All-Up
7.4.7. Rest of world (remaining countries of the LAMEA region) Insulin Delivery Devices Market All-Up
8. Competitive Landscape Analysis
8.1. Porter’s Five Forces Analysis
8.2. Industry – Competitive Landscape
8.3. Market Presence (Intensity Mapping)
8.4. Key Strategic Market Developments
9. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Footprint & Employee Strength
9.1.4. Product Offerings
9.1.5. Financials
9.1.6. Key Company Developments
9.2. Ypsomad Holding AG
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Footprint & Employee Strength
9.2.4. Product Offerings
9.2.5. Financials
9.2.6. Key Company Developments
9.3. F. Hoffmann-La Roche Ltd
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Footprint & Employee Strength
9.3.4. Product Offerings
9.3.5. Financials
9.3.6. Key Company Developments
9.4. Terumo Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Footprint & Employee Strength
9.4.4. Product Offerings
9.4.5. Financials
9.4.6. Key Company Developments
9.5. Insulet Corporation
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Footprint & Employee Strength
9.5.4. Product Offerings
9.5.5. Financials
9.5.6. Key Company Developments
9.6. Medtronic
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Footprint & Employee Strength
9.6.4. Product Offerings
9.6.5. Financials
9.6.6. Key Company Developments
9.7. Animas Corporation
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Footprint & Employee Strength
9.7.4. Product Offerings
9.7.5. Financials
9.7.6. Key Company Developments
9.8. Becton
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Footprint & Employee Strength
9.8.4. Product Offerings
9.8.5. Financials
9.8.6. Key Company Developments
9.9. Dickinson and Company
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Footprint & Employee Strength
9.9.4. Product Offerings
9.9.5. Financials
9.9.6. Key Company Developments
9.10. Sanofi
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Footprint & Employee Strength
9.10.4. Product Offerings
9.10.5. Financials
9.10.6. Key Company Developments
9.11. Dexcom, Inc.
9.11.1. Company Overview
9.11.2. Key Executives
9.11.3. Footprint & Employee Strength
9.11.4. Product Offerings
9.11.5. Financials
9.11.6. Key Company Developments
10. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
- Published Date: Dec-2021
- Report Format: Excel/PPT
- Report Code: HM17A-00-0818
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Insulin Delivery Devices Market by Product Type, by End User and by Region- Global Opportunities & Forecast, 2022-2029
$ 4,499.00 – $ 6,649.00
Why GMI Research
